Literature DB >> 18160473

The proteasome immunosubunit multicatalytic endopeptidase complex-like 1 is a T-cell-intrinsic factor influencing homeostatic expansion.

Dietmar M W Zaiss1, Natascha de Graaf, Alice J A M Sijts.   

Abstract

Homeostatic regulatory mechanisms maintain the constant ratios between different lymphocyte subsets in the secondary lymphoid organs. How this dynamic equilibrium is achieved, in particular following the clonal expansion and subsequent contraction of different cells after infection, remains poorly understood. Expression of the proteasome immunosubunits has been shown to influence not only major histocompatibility complex class I (MHC-I) antigen processing and thereby T-cell responses, but also the CD4/CD8 T-cell ratios in lymphoid organs. We examined the relationships between these different immunosubunit-mediated effects in mice of various proteasome subunit compositions during infection with Listeria monocytogenes. Mice that lacked the immunosubunit multicatalytic endopeptidase complex-like 1 (MECL-1) maintained enhanced CD4/CD8 T-cell ratios during infection, while MHC-I surface levels resembled those in wild-type (wt) mice. LMP7 gene-deficient mice, on the other hand, showed reduced MHC-I expression, while their splenic CD4/CD8 ratios were similar to those in wt mice. Remarkably, analysis of bone marrow-chimeric immunosubunit gene-deficient mice, reconstituted with a mixture of wt and LMP7- plus MECL-1-deficient bone marrow, revealed that the LMP7- plus MECL-1-deficient T-cell population maintained a higher CD4/CD8 T-cell ratio than the wt T-cell population before, during, and after infection and T-cell memory formation. Since in these mice the immunosubunit-positive and immunosubunit-negative T-cell populations were selected in the same thymus and expanded in the same lymphoid environments, our findings indicate that MECL-1 influences the homeostatic equilibrium between T-cell subsets, not through indirect extracellular signals, such as MHC-I expression or the cytokine milieu, but through direct effects on T-cell-intrinsic processes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160473      PMCID: PMC2258853          DOI: 10.1128/IAI.01134-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

Review 1.  Antigen processing by the proteasome.

Authors:  P M Kloetzel
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

2.  Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation.

Authors:  A Macagno; M Gilliet; F Sallusto; A Lanzavecchia; F O Nestle; M Groettrup
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

3.  Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation.

Authors:  J Li; B Schuler-Thurner; G Schuler; C Huber; B Seliger
Journal:  Int Immunol       Date:  2001-12       Impact factor: 4.823

4.  Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver.

Authors:  S Khan; M van den Broek; K Schwarz; R de Giuli; P A Diener; M Groettrup
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

Review 5.  The role of the ubiquitin-proteasome pathway in MHC class I antigen processing: implications for vaccine design.

Authors:  A Sijts; D Zaiss; P M Kloetzel
Journal:  Curr Mol Med       Date:  2001-12       Impact factor: 2.222

6.  Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.

Authors:  K Schwarz; M van Den Broek; S Kostka; R Kraft; A Soza; G Schmidtke; P M Kloetzel; M Groettrup
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

7.  Beta 2 subunit propeptides influence cooperative proteasome assembly.

Authors:  Mita De; Krupakar Jayarapu; Laura Elenich; John J Monaco; Robert A Colbert; Thomas A Griffin
Journal:  J Biol Chem       Date:  2002-11-26       Impact factor: 5.157

8.  Rates of processing determine the immunogenicity of immunoproteasome-generated epitopes.

Authors:  Parampal Deol; Dietmar M W Zaiss; John J Monaco; Alice J A M Sijts
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

9.  Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products.

Authors:  R E Toes; A K Nussbaum; S Degermann; M Schirle; N P Emmerich; M Kraft; C Laplace; A Zwinderman; T P Dick; J Müller; B Schönfisch; C Schmid; H J Fehling; S Stevanovic; H G Rammensee; H Schild
Journal:  J Exp Med       Date:  2001-07-02       Impact factor: 14.307

10.  Immunoproteasomes shape immunodominance hierarchies of antiviral CD8(+) T cells at the levels of T cell repertoire and presentation of viral antigens.

Authors:  W Chen; C C Norbury; Y Cho; J W Yewdell; J R Bennink
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

View more
  22 in total

1.  Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules.

Authors:  Danielle de Verteuil; Tara L Muratore-Schroeder; Diana P Granados; Marie-Hélène Fortier; Marie-Pierre Hardy; Alexandre Bramoullé; Etienne Caron; Krystel Vincent; Sylvie Mader; Sébastien Lemieux; Pierre Thibault; Claude Perreault
Journal:  Mol Cell Proteomics       Date:  2010-05-19       Impact factor: 5.911

Review 2.  Proteasomes in immune cells: more than peptide producers?

Authors:  Marcus Groettrup; Christopher J Kirk; Michael Basler
Journal:  Nat Rev Immunol       Date:  2009-12-11       Impact factor: 53.106

Review 3.  Emerging roles of immunoproteasomes beyond MHC class I antigen processing.

Authors:  Frédéric Ebstein; Peter-Michael Kloetzel; Elke Krüger; Ulrike Seifert
Journal:  Cell Mol Life Sci       Date:  2012-03-02       Impact factor: 9.261

4.  Functional module search in protein networks based on semantic similarity improves the analysis of proteomics data.

Authors:  Desislava Boyanova; Santosh Nilla; Gunnar W Klau; Thomas Dandekar; Tobias Müller; Marcus Dittrich
Journal:  Mol Cell Proteomics       Date:  2014-05-07       Impact factor: 5.911

5.  Molecular characterization and expressional affirmation of the beta proteasome subunit cluster in rock bream immune defense.

Authors:  Saranya Revathy Kasthuri; Navaneethaiyer Umasuthan; Ilson Whang; Bong-Soo Lim; Hyung-Bok Jung; Myung-Joo Oh; Sung-Ju Jung; Sang-Yeob Yeo; Sung Yeon Kim; Jehee Lee
Journal:  Mol Biol Rep       Date:  2014-05-28       Impact factor: 2.316

6.  PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo.

Authors:  Natascha de Graaf; Mary J G van Helden; Kathrin Textoris-Taube; Tomoki Chiba; David J Topham; Peter-Michael Kloetzel; Dietmar M W Zaiss; Alice J A M Sijts
Journal:  Eur J Immunol       Date:  2011-03-01       Impact factor: 5.532

7.  Proteasome immunosubunits protect against the development of CD8 T cell-mediated autoimmune diseases.

Authors:  Dietmar M W Zaiss; Cornelis P J Bekker; Andrea Gröne; Benedicte A Lie; Alice J A M Sijts
Journal:  J Immunol       Date:  2011-07-29       Impact factor: 5.422

8.  Unexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses.

Authors:  Scott E Hensley; Damien Zanker; Brian P Dolan; Alexandre David; Heather D Hickman; Alan C Embry; Cara N Skon; Kristie M Grebe; Thomas A Griffin; Weisan Chen; Jack R Bennink; Jonathan W Yewdell
Journal:  J Immunol       Date:  2010-03-12       Impact factor: 5.422

Review 9.  Proteostasis Dysfunction in Aged Mammalian Cells. The Stressful Role of Inflammation.

Authors:  Diego Ruano
Journal:  Front Mol Biosci       Date:  2021-06-17

10.  Pre-existing virus-specific CD8(+) T-cells provide protection against pneumovirus-induced disease in mice.

Authors:  Mary J G van Helden; Peter J S van Kooten; Cornelis P J Bekker; Andrea Gröne; David J Topham; Andrew J Easton; Claire J P Boog; Dirk H Busch; Dietmar M W Zaiss; Alice J A M Sijts
Journal:  Vaccine       Date:  2012-08-29       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.